Stocks
Anika Therapeutics (ANIK) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 1.44% | -5.20% | -38.9% | -36.6% | -7.58% | -8.26% | ||
| Changes by years, y/y, % | +10pp | -7pp | -34pp | +2pp | +29pp | -2.9% | |||
Anika Therapeutics. ROE, %
Anika Therapeutics. ROE, changes, pp
Anika Therapeutics (ANIK) ROE US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROE, % | ? | -38.2% | -41.1% | -22.5% | -7.58% | -8.26% | -8.26% | |
| Changes by years, y/y, % | -1pp | -6pp | +32pp | +29pp | +30pp | |||
| Changes by quarters, q/q, % | -2pp | -3pp | +19pp | +15pp | -1pp | |||
